The document summarizes key concepts in pharmacology including:
1) Pharmacodynamics is the study of how drugs act on the body by mimicking chemical messengers. Dose-response relationships describe the body's response to varying drug concentrations.
2) Pharmacokinetics describes the movement of drugs through the body via processes of liberation, absorption, distribution, metabolism and excretion (LADME).
3) Drug effects can be primary (intended) or secondary (side effects), and their onset and duration depends on route of administration (rapid for IV, delayed for oral). Drug interactions can have additive, synergistic, antagonistic or potentiating effects.
DRUG ACTION
For more information regarding PHARMACOVIGILANCE, CLINICAL RESEARCH, CLINICAL DATA MANAGEMENT & DRUG REGULATORY AFFAIRS kindly contact us on 9028839789
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
DRUG ACTION
For more information regarding PHARMACOVIGILANCE, CLINICAL RESEARCH, CLINICAL DATA MANAGEMENT & DRUG REGULATORY AFFAIRS kindly contact us on 9028839789
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
1. Week 2 (Pharma)
Pharmacodynamics
- is the study of the effect of drugs on the
body.
- Drugs act within the body to mimic the
actions of the body’s own chemical
messengers.
Dose-Response Relationship
› is the body’s physiological response to
changes in drug concentration at the
site of action.
› Potency – refers to the amount of drug
needed to elicit a specific physiologic
response to a drug.
- How much drug to experience relief
› Efficacy – magnitude of effect a drug
can cause when exerting its maximal
effect. How effective the drugs.
› Maximal efficacy – the point at which
increasing a drug dosage no longer
increases the desired therapeutic
response. e.g., if the drug is not
effective, change the drug. Do not
increase the dosage.
Parameters of Drug Action
› Therapeutic Index – (TI) describes the
relationship between the therapeutic
dose of a drug (ED50) and the toxic
dose of a drug (TD50)
› Therapeutic dose of a drug (ED50) – is
the dose of a drug that produces a
therapeutic response in 50% of the
population.
› Toxic dose of a drug (TD50) – is the
dose that produces a toxic response in
50% of the population.
Example: 1000 paracetamol is still
acceptable, more than that dosage is not.
Every 4-6 hours.
› If the ED50 and TD50 are close- drugs
have a narrow therapeutic index. It
requires close monitoring to ensure
patient safety.
› Onset – is the time it takes for a drug to
reach the minimum effective
concentration (MEC) after
administration. period you take
medication.
› Time from drug administration to first
observable effect (T0-T1)
› Peak – occurs when it reaches its
highest concentration in the
blood/plasma concentration. T0-T2
- Free from the pain. You feel best not
better. Less or no more symptoms.
› Duration of action – is the length of
time the drug exerts a therapeutic
effect.
Therapeutic Drug Monitoring
› Drug concentration can be determined
by measuring peak and trough drug
2. levels. For specialized type of drug:
antibiotics, vancomycin (for infection
develop resistance that needed level up
or potent medication.)
› peak – highest plasma concentration.
30 minutes after infusion.
› trough – lowest plasma concentration.
30 minutes prior to the next infusion.
Importance of P and T
- To know when the next dose will drug
will be next administer.
Theories of Drug Action
A. Drug-Receptor Interaction
› Certain portion of drug molecule (active
site) selectively combines with some
molecular structure (reactive site) on
the cell to produce a biologic effect
› Receptor site- drugs act at specific areas
on cell membranes; react with certain
chemicals to cause an effect within the
cell
› “Lock and Key Theory”- specific
chemical (key) approaches a cell
membrane and finds fit (the lock) at
receptor site- affects enzyme system
within cell- produce certain effects.
› Drug + Receptor=Effect
B. Drug-Enzyme Interaction
› Interferes with enzyme systems that act
as catalyst from various chemical
reactions
› If single step in one of enzyme system is
blocked = normal function is disrupted
› No receptor site.
C. Nonspecific Drug Interaction
› Act by biophysical means that do not
affect cellular/enzymatic reactions.
› drugs do not bind to receptors but
instead saturate the water or lipid part
of a cell- drug actions occur based on
the degree of saturation.
› Neutralization of stomach acid by
antacids (tinutunaw ang hydrochloric
secretion in the body.)
D. Selective Toxicity
› Specific action on cellular structures
that are unique to the microbe.
› All chemotherapeutic agents would act
only in one enzyme system needed for
life of a pathogen or neoplastic cell.
› It is essential to the pathogen but not to
the host.
› One enzyme only is affected and not as
a whole.
Drug Response
1.Primary- always desirable/ expected and
physiologic effects
Glutathione- Detoxify the liver which whitens
the skin.
2.Secondary- desirable or undesirable
3. › Example: Diphenhydramine generic
name (Benadryl) brand name for rhinitis
› Primary effect: antihistamine; treat
symptoms of allergy
› Secondary: Drowsiness
Classification of Drug Action
1.Rapid- few seconds to minutes
› - IV, SL (sub-lingual, under the tongue),
Inhalations
2. Intermediate- 1-2 hours after administration
› - IM, SC
3. Delayed/Slow- several hours after
administration
› - Oral, rectal
Categories of Drug Action
1.Stimulation/Depression
› Stimulation- increased rate of cell
activity/ secretion from the gland. E.g.,
T3/T4 for hypothyroidism
› Depression- decreased cell activity and
function of a specific organ. E.g., Iodine,
propylthiouracil
2. Replacement- replaces essential body
compounds
› Example: Insulin
› Type 1 DM: absence of insulin and beta
cells. Inborn error. Insulin replacement
needed for actual hormone.
› Type 2 DM: is not genetic. Faulty
lifestyle habit. Middle-aged individual.
Can be corrected by diet lifestyle.
› GDM (gestational diabetes mellitus) –
occur during pregnancy of women. Too
old to be pregnant and physique.
3. Inhibition/Killing of Organism
› Interfere with bacterial cell growth
› Example: Antibiotics (kills bacteria)
4. Irritation
› Example: Laxative (constipation)-
irritate the inner wall of colon or lower
GI tract---increased peristalsis---
increased defecation.
Drug-Drug Interaction
1.Additive Effect-2 drugs with similar actions
are taken for a doubled effect
› 1+1=2
› Ibuprofen + paracetamol= added
analgesic effect
› Codeine with acetaminophen = better
pain control
2. Synergistic- combined effect of 2 drugs is
greater than the sum of the effect of each drug
given alone; 1+1=3
› Aspirin = 30% analgesic effect
› codeine – 30% analgesic effect
› combination = 90% analgesic effect
3. Potentiation- a drug that has no effect
enhances the effects of the second drug
› 0+1=2
› Alcohol enhances the analgesic activity
of aspirin.
› Prozac + Zestril
4. 4. Antagonistic- one drug inhibits the effect of
another drug
› 1+1=0
› Tetracycline + antacid= decreased
absorption of tetracycline
Adverse Drug Effects
1.Side Effects
› Results from the pharmacologic effects
of the drug
› Most common as a result of lack of
specificity of action within the
therapeutic range.
2. Allergic Reactions
› Unpredictable adverse drug effects;
more serious
› Response to patient’s immunological
system to the presence of the drug
› Do not occur unless the patient has
been previously exposed to the agent/
chemical related compound
3. Idiosyncratic Reaction
› Occurs when the patient is first to the
drug
› Abnormal reactivity to the drug caused
by a genetic difference between the
patient and normal individual.
› a patient with G6PD deficiency will have
anemia by using antioxidants.
4. Toxicity
› The degree to which a drug can be
poisonous and thus harmful to the
human body.
5. Iatrogenic responses
› Unintentional responses as a result of
medical treatment
› Nephrotoxicity; ototoxicity
› Vitamin d and calcium is
PHARMACOKINETICS
› is the process of drug movement
throughout the body that is necessary
to achieve drug action.
› Processes: LADME
1. Liberation
2. Absorption
3. Distribution
4. Metabolism –biotransformation
5. Excretion – elimination
6. Liberation
5. › is the first step in the process by which
medication enters the body and
liberates the active ingredient that has
been administered.
– Three (3) steps:
› Disintegration
› Disaggregation
› Dissolution
› The characteristics of a medication's
excipient play a fundamental role in
creating a suitable environment for the
correct absorption of a drug.
› This can mean that the same dose of a
drug in different forms can have
different bioequivalence, as they yield
different plasma concentrations and
therefore have different therapeutic
effects.
ABSORPTION
› is the movement of the drug into the
bloodstream after administration.
› 80% of drugs are taken by mouth –
enteral.
› Movement of drug molecules from site
of administration to circulatory system
Movement of drug particles from GIT to body
fluids involve 3 processes:
1. Passive transport
› Diffusion – drugs move across the cell
membrane from an area of higher
concentration to one of lower
concentration.
2. Facilitated diffusion –Active transport
– requires a carrier such as enzyme or protein
to move the drug against a concentration
gradient. Energy is required.
3. Pinocytosis – is the process by which
cells carry a drug across their membrane by
engulfing the drug particles in a vesicle
DISTRIBUTION
› process by which drug becomes
available to body fluids and tissues.
› is the movement of the drug from the
circulation to body tissues
METABOLISM
Also known as biotransformation is the process
by which the body chemically changes drugs
into a form that can be excreted.
› First-pass effect or first-pass
metabolism
› GI tract --- intestinal lumen -- liver---
some drugs are metabolized to an
inactive form and excreted--- reduced
amount of active drug
› liver enzymes – cytochrome P450
system – convert drugs to metabolites.
› decreased drug metabolism rate will
result in excess drug accumulation that
can lead to toxicity.
› Drug half-life is the time it takes for the
amount of drug in the body to be
reduced by half.
Example:
› Ibuprofen has a half-life of about 2
hours.
6. › if the patient takes 200 mg, in 2 hours,
50% of the drug will be gone, leaving
100 mg.
› after 2 hours - 50 mg.
› after 2 hours – 25 mg
› after 2 hours – 12.5 mg
› after 2 hours – 6.25 mg
Factors affecting biotransformation
1. Genetic- some people metabolize drugs
rapidly, others more slowly
2. Physiologic
3. Liver disease- do not bombarded with
medication.
4. Infants- decreased rate of metabolism.
No antibiotics, yes to vitamins since the
organs are underdeveloped.
5. Elderlies- decreased liver size, blood
flow, enzyme production- slows
metabolism
6. Environment- cigarettes may affect the
rate of some drugs.
7. Stressful environment- prolonged
illness, surgery, illness.
EXCRETION – ELIMINATION
› removal of the drug from the body.
Drug is changed into inactive form and
excreted by the body.
Routes:
› Kidney- main organ for drug
elimination: leave the body through
urine
› Free or/unbound/water soluble drugs-
filtered in the kidney
› (+) kidney disease- dose must be
decreased.
› kidneys – main route of drug excretion
› bile, lungs, saliva, sweat and breast
milk.
› urine pH influences drug excretion.
› normal urine pH 4.6-8
› acidic urine promotes elimination of
weak base drugs.
› alkaline urine promotes elimination of
weak acid drugs.
› prerenal, intrarenal and postrenal
conditions.
Terminologies
L = Liberation, the release of the drug from its
dosage form.
A = Absorption, the movement of drugs from
the site of administration to the blood
circulation.
D = Distribution, the process by which drug
diffuses or is transferred from intravascular
space to extravascular space (body tissues).
M = Metabolism, the chemical conversion or
transformation of drugs into compounds which
are easier to eliminate.
E = Excretion, the elimination of unchanged
drug or metabolite from the body via renal,
biliary, or pulmonary processes.